Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Roc Opco LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is being processed in 1 distinct art unit, indicating a focused technical area for the company's current patent filings. The prosecution involves 1 distinct examiner, CAIN, JENNIFER LYNN, who is responsible for reviewing the application. This concentration in the assigned 1 distinct art unit allows for a specialized legal approach tailored to specific technical standards.
CAIN, JENNIFER LYNN is the busiest examiner for this portfolio, currently managing 1 pending office action. This workload represents the total pending matters for the company at this time. Because the portfolio is handled by 1 distinct examiner, the prosecution process is highly focused. Practitioners should prioritize understanding the specific preferences of CAIN, JENNIFER LYNN to advance the case toward allowance. Maintaining a direct line of communication with the assigned examiner is essential for resolving the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CAIN, JENNIFER LYNN | 1 | 45.0% | +70.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176242 | FORMULATION FOR THE TREATMENT OF FINE LINES AND WRINKLES AND USES THEREOF | CAIN, JENNIFER LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18176242 | FORMULATION FOR THE TREATMENT OF FINE LINES AND WRINKLES AND USES THEREOF | CAIN, JENNIFER LYNN | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18176242 | FORMULATION FOR THE TREATMENT OF FINE LINES AND WRINKLES AND USES THEREOF | CAIN, JENNIFER LYNN | 1655 | §101§102§103 | Final Rejection | — | Pending | Feb 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial